For patients with chronic obstructive ... a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

is to work with Qualcomm to 'digitally upgrade' its Respimat inhaler, introducing a new connectivity solution to improve medication adherence in chronic obstructive pulmonary disorder (COPD ...

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary ...

Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. If you're new ...

Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...